ser100
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT01987284)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Nociceptin receptorAGONIST
OPRL1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ser100
- ser100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01987284 | Phase 2 | Oct 1, 2013 | Government of Norway, Osaka University, Serodus ASA, Smerud Medical Research Denmark |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Norway | Government | 1 | 0 | 1 | 2013 |
| Osaka University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Serodus ASA | For profit | 1 | 1 | 1 | 2013 |
| Smerud Medical Research Denmark | For profit | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1